Employees: 01 (2023.0)Legal category: 5485Size: PMECreation date: 2015-11-23 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MARSEILLE (13006), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LANDI : revenue, balance sheet and financial ratios
PHARMACIE LANDI is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MARSEILLE (13006),
this company of category PME
shows in 2019 a net income positive of 123 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LANDI (SIREN 814941001)
Indicator
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
Net income
123 144 €
-39 070 €
-37 844 €
8 034 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2019, PHARMACIE LANDI generates positive net income of 123 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2019: 8 k€ -> 123 k€.
Net income (2019)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
123 144 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1775%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 5%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2019)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1774.916%
Financial autonomy (2019)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
5.096%
Asset age ratio (2019)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
Debt ratio
8773.902
-5674.963
-1931.411
1774.916
Financial autonomy
1.048
-1.701
-5.243
5.096
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
1774.922019
2017
2018
2019
Q1: 35.68
Med: 104.11
Q3: 243.61
Average+50 pts over 3 years
In 2019, the debt ratio of PHARMACIE LANDI (1774.92) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
5.1%2019
2017
2018
2019
Q1: 22.98%
Med: 40.68%
Q3: 60.84%
Average
In 2019, the financial autonomy of PHARMACIE LANDI (5.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 485.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2019)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
485.661
Liquidity indicators evolution PHARMACIE LANDI
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
Liquidity ratio
490.001
458.659
469.637
485.661
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
485.662019
2017
2018
2019
Q1: 119.99
Med: 167.03
Q3: 236.26
Excellent
In 2019, the liquidity ratio of PHARMACIE LANDI (485.66) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE LANDI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 205 transactions of similar company sales
in 2019,
the value of PHARMACIE LANDI is estimated at
1 530 461 €
(range 911 632€ - 2 172 455€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2019
205 transactions
911k€1530k€2172k€
1 530 461 €Range: 911 632€ - 2 172 455€
NAF 5 année 2019
Valuation method used
Net Income Multiple
123 144 €
×
12.4x
=1 530 462 €
Range: 911 633€ - 2 172 455€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 205 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LANDI with other companies in the same sector:
The revenue of PHARMACIE LANDI is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE LANDI profitable?
Yes, PHARMACIE LANDI generated a net profit of 123 k€ in 2019.
Where is the headquarters of PHARMACIE LANDI ?
The headquarters of PHARMACIE LANDI is located in MARSEILLE (13006), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE LANDI ?
The tax return of PHARMACIE LANDI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LANDI operate?
PHARMACIE LANDI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart